Stock Trading

Divis Lab Intraday Buy Call

Karvy Stock Broking Limited has maintained ‘Buy’ rating on Divis Divis Laboratories Ltd Laboratories Ltd stock with an intraday target of Rs 1530.

According to Karvy, day traders can purchase the stock between Rs 1440-1450 with a strict stop loss of Rs 1400. The stock pricing becomes more attractive, and reach above Rs 1540, if the stock market remains on positive track.

Sensex Closes 383.20 Pts Up At 14,961.07

Indian equities closed on an encouraging note, on Tuesday (August 05), on Sensex Closes 383.20 Pts Up At 14,961.07the back of good buying action seen across all segments, with Bankex (6.65%) and Realty (6.56%) sectors being the major gainers among the sectoral indices.

Volatility jitters, which were seen during the early trading sessions, turned down in the late closing sessions with markets zooming 383.20 points.

BSE Midcap and Smallcap index closed the day positively after gaining 1.76% and 1.26% respectively.

Asian stocks reported a declension with mining companies being in the front line.

Sensex Gains 71 Pts; M&M, ACC Climb Up

The Sensex, which recovered smartly after a sharp decline from upper Sensex Gains 71 Pts; M&M, ACC Climb Up   levels, trading positively on account of good buying action witnessed in select blue chip stocks.

At 1:26 pm, the Sensex gained 71.07 points at 14,648.94 over its previous closing mark, while the broad-based NSE Nifty stood at 4413.55, up 17.20 points.

The major gainers in the Sensex were Mahindra & Mahindra (4.5%), ACC (3.15%), HDFC Bank (3.8%), ICICI Bank (2.6%), State Bank of India (2.4%) and Hindustan Unilever (2%).

HCL Tech Intraday Buy Call

Stock market analysts have maintained ‘buy’ rating on HCL Technologies HCL Technologies Limitedstock with an intraday target of Rs 225.

According to them, interested traders can purchase the stock above Rs 221 with a strict stop loss of Rs 217. If the stock market remains positive, the stock pricing becomes more attractive, and reach above Rs 227.
 

Ranbaxy Intraday Buy Call

Stock market analysts have maintained ‘buy’ rating on Ranbaxy Ranbaxy Laboratories LtdLaboratories stock with an intraday target of Rs 531.

According to them, interested traders can purchase the stock above Rs 525 with a strict stop loss of Rs 521. If the stock market remains positive, the stock pricing becomes more attractive, and reach above Rs 532.
 
Shares of the company, on Monday (August 4), closed at Rs 524 on the Bombay Stock Exchange (BSE). The total volume of shares traded at the BSE was 829050. The share price has seen a 52-week high of Rs 613.70 and a low of Rs 299.90 on BSE.

Stock Markets Still In Safety Zone, Says Vishwas Agarwal

Indian stock markets ended that day negatively amid volatility. Heavy  Stock Markets Still In Safety Zone, Says Vishwas Agarwal buying activity was seen in FMCG, metal, healthcare stocks, whereas oil, power and consumer goods stocks went down.

The 30-share index Sensex, on Monday (August 4), opened with a negative gap of 62.05 points at 14,594.64 the back of profit booking. After few minutes, Sensex moved into the positive terrain to trade on a flat note.

BSE Midcap and Smallcap index closed after gaining 1.77% each.

Pages